Medical Devices Industry Reports Coronary Stents Market | Page 2

REPORT DESCRIPTION
Coronary Stents Market – Overview
Stents are medical devices intended to use for the treatment of blocked vascular paths and the procedure used to
reduce the blockages is known as percutaneous transluminal coronary angioplasty (PTCA). The stents used for
arterial blockage are known as coronary stents or heart stents. Coronary stents can be either of the three types,
which are bare metal stents, drug eluting stents, and bioabsorbable stents. Although bare metal stents
dramatically improves angiographic and clinical outcome of patients, the rate of restenosis is 20–30%. This is a
major factor limiting the usage of bare metal stents and development of next generation of drug eluting stents.
The global coronary stents market size is estimated to be valued at US$ 7,814.4 million in 2018, and is expected
to witness a CAGR of 6.8% over the forecast period (2018 – 2026).
Stents implantation being non-invasive surgery is increasingly gaining popularity as compared to more invasive
bypass surgeries, owing to lower rate of discomfort and shorter recovery time. Moreover, cardiovascular
diseases are considered as the leading cause of morbidity and mortality across the world, in turn fueling demand
for coronary stents. According to American Heart Association, 2015, more than 17.3 million people die every
year due to cardiovascular disease.
© Coherent market Insights. All Rights Reserved